Burger Menu

Site by

< Back to News

Partech Newsletter: Pocketful of Sunshine, €38M raised by our portfolio companies and new contracts!

Looks like that summer started off in style for our portfolio companies! Bestmile has been selected to join the World Economic Forum Tech Pioneers of 2018, Privitar opened an office in New York and won a new contract (see below), Akeneo announced new products and updates to its flagship PIM product, and Sigfox reachedfull deployment in Hong Kong! And on the money front, Toss, the world’s fastest growing fintech service delivering consumer finance on mobile, raised $40 million. Did you know that Toss founder is a former dentist

 We're shining strong too with events dedicated to our portfolio companies: the Seminar on Retail (an oldie but goodie from our previous newsletter, there's the wrap-up) and the CFOs Seminar – continuing our commitment to ongoing support and insights for our constituents. We also organized a Business Club meeting espousing relations between start-ups and corporate groups, with our own Karen Noël presenting, and as far as the Paris Saclay Seed Fund is concerned, we hosted a start-ups' pitch session in the splendid Chanel offices!

 The Partech European team members shared a fun day of fast-paced karting and spent quality time together to reflect on our current projects and how far we have come since Partech’s inception in 1982. Let the good times roll ! More to come after the summer break. Teasing ;-)

 And do not miss our new section at the end of this newsletter: a recommended book by a Partech team member. Omri gets the ball rolling this month!

 Have a great read!


€38M raised by our portfolio companies

 

TOSS Toss CEO, Seung-Gun Lee

 

  • Toss  raised €34M ($40M) from Singapore sovereign wealth fund GIC and Sequoia China, cash needed for Toss’s registered user base which has doubled over the past year to reach eight million consumers!
  • Sensome  raised €4.6M ($5.3M) to bring the first connected stroke device to market. “This financing round will enable us to bring Clotild through clinical testing and to the European market" said CEO Franz Bozsak. Clotild is a connected guidewire for the treatment of ischemic stroke, the world’s leading cause of disability. 


Read the full newsletter here and subscribe to get the next issue directly in your inbox!



< Back to News